IMNM
Immunome Inc.
Immunome Inc. (IMNM) has 8 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 9, 2026.
The most active filer is Director Barchas Isaac with 4 filings. Insiders have net sold $10.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Clay Siegall
- Employees:177
- HQ:Bothell, WA, US
- IPO:2020-10-02
Insider Buying
$308K
reported purchases (SEC code P)
Insider Selling
$10.5M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$2.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Horn KinneyFirst filing | CHIEF BUSINESS OFFICER | Sale | 1,092 | $27K | Jul 9 | SEC ↗ |
| Director | Sale | 83,094 | $2.0M | Jul 7 | SEC ↗ | |
| Director | Sale | 16,906 | $409K | Jul 7 | SEC ↗ | |
| Chief Medical Officer | Sale | 55,000 | $1.2M | Jul 7 | SEC ↗ | |
Barchas IsaacFirst filing | Director | Sale | 101,050 | $2.1M | Jul 3 | SEC ↗ |
Barchas IsaacFirst filing | Director | Sale | 100,000 | $2.3M | Jul 3 | SEC ↗ |
Lechleider RobertFirst filing | Chief Medical Officer | Sale | 55,000 | $1.1M | Jun 29 | SEC ↗ |
Rosett MaxFirst filing | Chief Financial Officer | Sale | 60,000 | $1.1M | Jun 17 | SEC ↗ |
| Director | Sale | 10,500 | $204K | Jun 9 | SEC ↗ | |
| Director | Purchase | 10,500 | $204K | Jun 9 | SEC ↗ | |
BIENAIME JEAN JACQUESFirst filing | Director | Purchase | 5,000 | $104K | May 19 | SEC ↗ |
Related companies
Immunome Inc. is in the Healthcare sector.